Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Atara Posner(The University of Melbourne), Linda Mileshkin(Peter MacCallum Cancer Centre), Tharani Sivakumaran(The University of Melbourne), Andrew Fellowes(Peter MacCallum Cancer Centre), Niko Thio(Peter MacCallum Cancer Centre), Anna DeFazio(The University of Sydney), Samantha Webb(Peter MacCallum Cancer Centre), Andrew Pattison(University of Melbourne), David D.L. Bowtell(The University of Melbourne), Ian Collins(St. James's Hospital), Mark Warren(Bendigo Health), Penelope Schofield(Swinburne University of Technology), Colin S. Wood(University of Glasgow), Nicholas Wilcken(Westmead Hospital), Rodney J. Hicks(Flinders Medical Centre), Christos S. Karapetis(Clínica Alemana), Bo Gao(Sun Yat-sen University), Narayan Karanth(Cancer Council Northern Territory), Christopher Steer(Albury Wodonga Health), Richard W. Tothill(The University of Melbourne), Krista Fisher(The University of Melbourne), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Stephen B. Fox(Peter MacCallum Cancer Centre), Owen W.J. Prall(The University of Melbourne), Madhu Singh(Barwon Health), Gary Richardson(Cabrini Hospital)
Cited by 17
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k